SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-008607
Filing Date
2017-05-10
Accepted
2017-05-10 16:09:12
Documents
19
Period of Report
2017-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170509_8k.htm 8-K 28182
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 110496
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 6418
4 a14.jpg GRAPHIC 43752
5 a13.jpg GRAPHIC 86116
6 a12.jpg GRAPHIC 147784
7 a11.jpg GRAPHIC 133043
8 a10.jpg GRAPHIC 78308
9 a9.jpg GRAPHIC 108177
10 a8.jpg GRAPHIC 111248
11 a7.jpg GRAPHIC 133280
12 a6.jpg GRAPHIC 131862
13 a5.jpg GRAPHIC 93641
14 a4.jpg GRAPHIC 112163
15 a3.jpg GRAPHIC 59740
16 a2.jpg GRAPHIC 271954
17 a1.jpg GRAPHIC 43752
18 ex99-1img002.jpg GRAPHIC 3740
19 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-008607.txt   2297139
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 17830294
SIC: 2834 Pharmaceutical Preparations